Predictors of fluoxetine remission for hospitalized patients with major depressive disorder
โ Scribed by Ching-Hua Lin; Hsien-Yuan Lane; Cheng-Chung Chen; Suh-Hang Hank Juo; Cheng-Fang Yen
- Book ID
- 108962699
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 81 KB
- Volume
- 65
- Category
- Article
- ISSN
- 1323-1316
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,
## Abstract ## Objective Investigation of the characteristics of patients being treated with antidepressants would be useful in determining which patients would most likely benefit from antidepressant. The purpose of this study was to examine the possible predictors of response to sertraline in ma